The number of people with susceptibility test result for rifampicin in Burkina Faso
Burkina Faso: The number of people with susceptibility test result for rifampicin was 3,042 in 2021. ▲ Rising
Latest (2021)
3,042
Change on year
down 7.3%
World rank
40th
of 155 countries
All-time high
3,282
in 2020
All-time low
806
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Burkina Faso, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Burkina Faso is 3,042, measured in 2021.
The figure is down 7.3% on the previous year and up 277.4% over five years.
That places Burkina Faso 40th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Burkina Faso, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 806 | — |
| 2018 | 1,150 | +42.7% |
| 2019 | 1,733 | +50.7% |
| 2020 | 3,282 | +89.4% |
| 2021 | 3,042 | -7.3% |
Burkina Faso compared with similar countries
- Burkina Faso's 3,042 is above the median for low income countries, which is 1,934, 1.6× the median. (15 countries reporting)
- Burkina Faso's 3,042 is above the median for Sub-Saharan Africa, which is 2,015, 1.5× the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,230 | 806 | 1,733 | 3 |
| 2020s | 3,162 | 3,042 | 3,282 | 2 |
Countries ranked near Burkina Faso
More health data for Burkina Faso
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8925 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,142 deaths per 1,000 people (2090)
- Number of infants who die before age 1 13,085 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 4 (2025)
- Population ages 00-04, female, annual growth rate 0.8681 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0693 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.7133 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Burkina Faso?
- The number of people with susceptibility test result for rifampicin in Burkina Faso was 3,042 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Burkina Faso?
- The highest recorded value was 3,282 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Burkina Faso?
- The lowest recorded value was 806 in 2017.
- How does Burkina Faso rank for the number of people with susceptibility test result for rifampicin?
- Burkina Faso ranks 40th out of 155 countries with data for 2021.
- Where does this Burkina Faso data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).